These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2986823)
1. Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study. Klefström P; Holsti P; Gröhn P; Heinonen E; Holsti L Cancer; 1985 Jun; 55(12):2753-7. PubMed ID: 2986823 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Gröhn P; Heinonen E; Klefström P; Tarkkanen J Cancer; 1984 Aug; 54(4):670-4. PubMed ID: 6744203 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole. Klefström P; Gröhn P; Heinonen E; Holsti L; Holsti P Cancer; 1987 Sep; 60(5):936-42. PubMed ID: 3300953 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Arnaud JP; Buyse M; Nordlinger B; Martin F; Pector JC; Zeitoun P; Adloff A; Duez N Br J Surg; 1989 Mar; 76(3):284-9. PubMed ID: 2655812 [TBL] [Abstract][Full Text] [Related]
5. Levamisole as adjuvant immunotherapy in breast cancer. Treurniet-Donker AD; Meischke-de Jongh ML; van Putten WL Cancer; 1987 May; 59(9):1590-3. PubMed ID: 3828958 [TBL] [Abstract][Full Text] [Related]
6. Increased breast-cancer recurrence rate after adjuvant therapy with levamisole. A preliminary report. Executive Committee of the Danish Breast Cancer Cooperative Group. Lancet; 1980 Oct; 2(8199):824-7. PubMed ID: 6107500 [TBL] [Abstract][Full Text] [Related]
7. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Stotter AT; McNeese MD; Ames FC; Oswald MJ; Ellerbroek NA Cancer; 1989 Dec; 64(11):2217-25. PubMed ID: 2553241 [TBL] [Abstract][Full Text] [Related]
8. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Mate TP; Carter D; Fischer DB; Hartman PV; McKhann C; Merino M; Prosnitz LR; Weissberg JB Cancer; 1986 Nov; 58(9):1995-2002. PubMed ID: 3019514 [TBL] [Abstract][Full Text] [Related]
9. Levamisole in the treatment of advanced breast cancer. A ten-year follow-up of a randomized study. Klefström P; Nuortio L Acta Oncol; 1991; 30(3):347-52. PubMed ID: 2036245 [TBL] [Abstract][Full Text] [Related]
10. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843 [TBL] [Abstract][Full Text] [Related]
11. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma. Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241 [TBL] [Abstract][Full Text] [Related]
12. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Solin LJ; Recht A; Fourquet A; Kurtz J; Kuske R; McNeese M; McCormick B; Cross MA; Schultz DJ; Bornstein BA Cancer; 1991 Dec; 68(11):2337-44. PubMed ID: 1657351 [TBL] [Abstract][Full Text] [Related]
13. Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole. A randomized trial of the Southeastern Cancer Study group. Krauss S; Comas F; Perez C; Gordon D; Philpott G; Broun G; Mill W; Robbins R; Smalley R; Mendiondo O Am J Clin Oncol; 1984 Oct; 7(5):405-12. PubMed ID: 6391141 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. Chlebowski RT; Nystrom S; Reynolds R; Weiner JM; Bateman JR Oncology; 1988; 45(3):141-3. PubMed ID: 3285278 [TBL] [Abstract][Full Text] [Related]
15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation. Schreml W; Lang M; Betzler M; Schlag P; Lohrmann HP; Heimpel H; Herfarth C Eur J Cancer Clin Oncol; 1983 May; 19(5):607-13. PubMed ID: 6683632 [TBL] [Abstract][Full Text] [Related]
17. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma. Spitler LE; Sagebiel R N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349 [TBL] [Abstract][Full Text] [Related]
19. Isolated/primary CNS relapse in women in remission after ABMT for metastatic breast cancer. Ellis ED; Williams SF Bone Marrow Transplant; 1992 Feb; 9(2):147-9. PubMed ID: 1315184 [No Abstract] [Full Text] [Related]
20. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]